Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Top Cited Papers
Open Access
- 1 January 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 23 (1), 86-102
- https://doi.org/10.1681/asn.2010111210
Abstract
Inflammation contributes to the tubulointerstitial lesions of diabetic nephropathy. Toll-like receptors (TLRs) modulate immune responses and inflammatory diseases, but their role in diabetic nephropathy is not well understood. In this study, we found increased expression of TLR4 but not of TLR2 in the renal tubules of human kidneys with diabetic nephropathy compared with expression of TLR4 and TLR2 in normal kidney and in kidney disease from other causes. The intensity of tubular TLR4 expression correlated directly with interstitial macrophage infiltration and hemoglobin A1c level and inversely with estimated glomerular filtration rate. The tubules also upregulated the endogenous TLR4 ligand high-mobility group box 1 in diabetic nephropathy. In vitro, high glucose induced TLR4 expression via protein kinase C activation in a time- and dose-dependent manner, resulting in upregulation of IL-6 and chemokine (C-C motif) ligand 2 (CCL-2) expression via IκB/NF-κB activation in human proximal tubular epithelial cells. Silencing of TLR4 with small interfering RNA attenuated high glucose–induced IκB/NF-κB activation, inhibited the downstream synthesis of IL-6 and CCL-2, and impaired the ability of conditioned media from high glucose–treated proximal tubule cells to induce transmigration of mononuclear cells. We observed similar effects using a TLR4-neutralizing antibody. Finally, streptozotocin-induced diabetic and uninephrectomized TLR4-deficient mice had significantly less albuminuria, renal dysfunction, renal cortical NF-κB activation, tubular CCL-2 expression, and interstitial macrophage infiltration than wild-type animals. Taken together, these data suggest that a TLR4-mediated pathway may promote tubulointerstitial inflammation in diabetic nephropathy.Keywords
This publication has 64 references indexed in Scilit:
- Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injuryKidney International, 2011
- Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptorsAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulinCardiovascular Diabetology, 2010
- Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetesDiabetologia, 2009
- Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantationProceedings of the National Academy of Sciences of the United States of America, 2009
- Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other DiseasesPharmaceutical Research, 2008
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- TLR4 activation mediates kidney ischemia/reperfusion injuryJCI Insight, 2007
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJCI Insight, 2006
- Global and societal implications of the diabetes epidemicNature, 2001